← All stocks

Monopar Therapeutics

MNPR Net selling
CIK 0001645469 #2760 in the set updated 18 Sep 2026
Bought (12 mo)
$104.93K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$36.15M
$806.76K on a plan · $111.26 straight out of an exercise
Sold at will
$35.34M
3 of 13 sales
Net
−$36.05M
−$35.24M against sales at will

By person

12 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Tactic Pharma LLC entity
10% owner
$35.00M (1)
−$35.00M
272,026
4.05%
$30.97M
−68.2%
Tsuchimoto Kim R
Director
$455.57K (6) scheduled
−$455.57K
7,396
0.1102%
$841.96K
−35.6%
Anderson Raymond
Director
$351.19K (3) scheduled
−$351.19K
23,751
0.3538%
$2.70M
−11.7%
KLAUSNER ARTHUR J
Director
$343.89K (2)
−$343.89K
8,762
0.1305%
$997.47K
+41.9%
Vu Quan Anh
Chief Financial Officer
$104.93K (1)
+$104.93K
2,221
0.0331%
$252.84K
RIOUX PATRICE
Acting Chief Medical Officer
$111.26 (1) scheduled
−$111.26
5,065
0.0755%
$576.60K
+37.4%
Hendricks Diane
10% owner
567,580
8.46%
$64.61M
−7.1%
Robinson Chandler
Chief Executive Officer
162,082
2.41%
$18.45M
+204.8%
Cittadine Andrew
Chief Operating Officer
55,614
0.8286%
$6.33M
+44.0%
STARR CHRISTOPHER M
Director
5,173
0.0771%
$588.89K
0.0%
Radhakrishnan Karthik
Chief Financial Officer
1,550
0.0231%
$176.45K
TacticGem LLC entity
10% owner
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
KLAUSNER ARTHUR J
18 Dec 2025
Director
Sell
461
$68.09
$31.39K
KLAUSNER ARTHUR J
18 Dec 2025
Director
Sell
4,660
$67.06
$312.50K
Tactic Pharma LLC
24 Sep 2025
10% owner
Sell
550,229
$63.61
$35.00M

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 1
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 127,725
History held since 27 Sep 2018